Scientists at UC San Francisco put AI to work analyzing study participants’ gaits, then had it develop personalized brain ...

Medtronic has promoted the head of its Cardiac Implantables Technology Development Center to be its new chief technology ...

Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy.

Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Global Neuromodulation Devices Market OverviewThe global neuromodulation devices market is poised to witness substantial ...

"I noticed I was having abnormal heartbeats where I felt like I would need to catch my breath," said Adamy. A single mom with a career in health care and two young children, Adamy chalked up her ...

Medtronic MDT is set to release second-quarter fiscal 2026 results on Nov. 18, before the market opens. The MedTech giant ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first ...